Carpe Diem
Tag: value investing
🔮 Palantir (PLTR): The Next Generative Monopoly or an Over-Allocated Thesis?
Is Palantir Technologies (PLTR) the next epoch-defining monopoly, or is the public market dangerously over-allocating capital to a glorified data consulting firm? In this deep-dive Carpe Diem audit, we tear apart Palantir's structural AWS-style enterprise data lock-in, analyze the psychological profile required to survive extreme 80% growth drawdowns, and reveal the exact framework necessary to distinguish a generational compounding engine from an over-hyped momentum mirage.
🐺 Contrarian Investing: The Sheep Masquerading as a Lone Wolf
Jason Zweig’s brutal definition of “contrarian” captures one of investing’s great ironies: everyone wants to be seen as independent, but almost nobody wants to pay the emotional, reputational, and business price of actually thinking differently.
Even Fizz Shows the Power of Dividends ☀️🥤
Berkshire Hathaway now collects more than $800 million per year in Coca-Cola dividends. Sometimes the most powerful investment strategy is also the simplest: buy great businesses and let time do the work.
When AI Gets Crowded, Small Caps Get Interesting...
As the AI trade gets crowded, money is rotating into small caps and overlooked stocks — many backed by recent insider buying. A familiar setup for long-term returns.
When Policy Sneezes, Insurers Catch a Cold
Policy headlines shook UnitedHealth and the insurer space today. But with insiders buying aggressively at much higher prices, this selloff may say more about fear than fundamentals.